TCRαβ/CD3 Disruption Enables CD3-specific Antileukemic T Cell Immunotherapy

JCI insight - United States
doi 10.1172/jci.insight.99442
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Society for Clinical Investigation

Related search

Differential Signal Transduction via T-Cell Receptor CD3 Zeta 2, CD3 Zeta-Eta, and CD3 Eta 2 Isoforms.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1991English

Variability of CD3 Membrane Expression and T Cell Activation Capacity

Cytometry Part B - Clinical Cytometry
Forensic MedicinePathologyHistologyCell Biology
2009English

The T Cell Receptor/Cd3 Complex: A Dynamic Protein Ensemble

Annual Review of Immunology
AllergyImmunology
1988English

Selected Signalling Proteins Recruited to the T Cell Receptor-Cd3 Complex

Immunology
AllergyImmunology
2017English

CD3 Down-Regulating Factor in Patients With Adult T Cell Leukemia.

Japanese Journal of Clinical Immunology
1993English

Cooperative Interactions of Simian Immunodeficiency Virus Nef, AP-2, and CD3- Mediate the Selective Induction of T-Cell Receptor-Cd3 Endocytosis

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2003English

Degradation of T Cell Receptor (TCR)–CD3-ζ Complexes After Antigenic Stimulation

Journal of Experimental Medicine
MedicineAllergyImmunology
1997English

A Future for CD3 Antibodies in Immunotherapy of Type 1 Diabetes

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

The E3 Ubiquitin Ligase GRAIL Regulates T Cell Tolerance and Regulatory T Cell Function by Mediating T Cell Receptor-Cd3 Degradation

Immunity
Infectious DiseasesAllergyImmunology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy